GlassScriptPhysician profile
Nikhil Jagan
NPI 1427480284
$19,699.33
in general payments reported to CMS, 2019-2025
31 companies · $1,279 in 2025
The $1,279 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $453 · 2020: $163 · 2021: $162 · 2022: $183 · 2023: $16K · 2024: $1,032 · 2025: $1,279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $9,070 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,000 · Food and Beverage: $2,740 · Travel and Lodging: $928.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $9,069.99 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,000.00 |
| Food and Beverage | $2,740.26 |
| Travel and Lodging | $928.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,928.41 | 2023 | Da Vinci Surgical System, Ion |
| Incyte Corporation | $6,000.00 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $1,181.64 | 2019-2025 | Fasenra, Airsupra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $452.05 | 2019-2025 | Ofev, Jascayd |
| Grifols USA, LLC | $319.13 | 2022-2025 | Prolastin-C Liquid |
| Insmed, INC. | $195.47 | 2021-2025 | Arikayce, Brinsupri |
| Amgen INC. | $185.83 | 2021-2025 | Tezspire |
| Harmony Biosciences LLC | $166.12 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $162.40 | 2021-2025 | Dupixent |
| Merck Sharp & Dohme LLC | $133.31 | 2024-2025 | Winrevair |
| Actelion Pharmaceuticals US, INC. | $110.89 | 2019-2025 | Uptravi, Opsynvi, Opsumit |
| Astellas Pharma US INC | $99.99 | 2021 | |
| Mylan Specialty L.P. | $95.31 | 2019-2024 | Yupelri |
| Jazz Pharmaceuticals INC. | $80.93 | 2024-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $70.33 | 2024-2025 | Lumryz |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $69.60 | 2019-2025 | |
| Glaxosmithkline, LLC. | $63.15 | 2019-2025 | Nucala |
| Electromed, INC. | $53.94 | 2019-2025 | Smartvest |
| Takeda Pharmaceuticals U.S.A., INC. | $46.81 | 2023-2025 | Glassia |
| Philips North America LLC | $44.76 | 2019-2020 | |
| Genzyme Corporation | $38.37 | 2025 | |
| Lilly USA, LLC | $28.67 | 2025 | Mounjaro, Zepbound |
| Zoll Respicardia, INC. | $26.08 | 2023 | Remede System |
| Ani Pharmaceuticals, INC. | $25.75 | 2024 | Purified Cortrophin Gel |
| Genentech USA, INC. | $25.63 | 2023 | Xolair |
| Baxter Healthcare | $22.95 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Alexion Pharmaceuticals, INC. | $19.40 | 2024 | Ultomiris |
| Mallinckrodt Hospital Products INC. | $18.18 | 2023 | Acthar |
| Bayer Healthcare Pharmaceuticals INC. | $15.07 | 2022 | |
| Shire North American Group INC | $12.91 | 2019 | |
| Veran Medical Technologies, INC. | $6.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nikhil Jagan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.